Request for Covid-19 Impact Assessment of this Report

Pharmaceuticals

Global Antibiotics Active Pharmaceutical Ingredient (API) Market Growth 2021-2026

  • LP 4303025
  • 113 Pages
  • May 2021
  • Pharmaceuticals
Download Sample    Get Discount   
 
According to this latest study, the 2021 growth of Antibiotics Active Pharmaceutical Ingredient (API) will have significant change from previous year. By the most conservative estimates of global Antibiotics Active Pharmaceutical Ingredient (API) market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ xx million in 2020. Over the next five years the Antibiotics Active Pharmaceutical Ingredient (API) market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2026.

This report presents a comprehensive overview, market shares, and growth opportunities of Antibiotics Active Pharmaceutical Ingredient (API) market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2016 to 2021, in Section 2.3; and forecast to 2026 in section 11.7.

Penicillin Antibiotics

Cephalosporins

Carbapenem Antibiotics

Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 11.8.

Pharmaceutical Companies

Contract Manufacturing Organizations (CMOs)

Contract Development & Manufacturing Organizations (CDMOs)

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in Chapter 3.

Sandoz International

Centrient Pharmaceuticals

CordenPharma International

ACS DOBFAR

Nanjing Dorra Pharmaceutical Technology

DAEWOONG PHARMACEUTICAL

Parabolic Drugs

Penam Laboratories

ASIATIC DRUGS & PHARMACEUTICALS

Fresenius Kabi

The United Laboratories International Holdings

Aurobindo Pharma

Unimark Remedies

Savior Lifetec

Shenzhen Haibin Pharmaceutical

Sterile India

Zhejiang Jiuzhou Pharmaceutical

Kyongbo Pharm

1 Scope of the Report

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Antibiotics Active Pharmaceutical Ingredient (API) Consumption 2016-2026

2.1.2 Antibiotics Active Pharmaceutical Ingredient (API) Consumption CAGR by Region

2.2 Antibiotics Active Pharmaceutical Ingredient (API) Segment by Type

2.2.1 Penicillin Antibiotics

2.2.2 Cephalosporins

2.2.3 Carbapenem Antibiotics

2.3 Antibiotics Active Pharmaceutical Ingredient (API) Sales by Type

2.3.1 Global Antibiotics Active Pharmaceutical Ingredient (API) Sales Market Share by Type (2016-2021)

2.3.2 Global Antibiotics Active Pharmaceutical Ingredient (API) Revenue and Market Share by Type (2016-2021)

2.3.3 Global Antibiotics Active Pharmaceutical Ingredient (API) Sale Price by Type (2016-2021)

2.4 Antibiotics Active Pharmaceutical Ingredient (API) Segment by Application

2.4.1 Pharmaceutical Companies

2.4.2 Contract Manufacturing Organizations (CMOs)

2.4.3 Contract Development & Manufacturing Organizations (CDMOs)

2.5 Antibiotics Active Pharmaceutical Ingredient (API) Sales by Application

2.5.1 Global Antibiotics Active Pharmaceutical Ingredient (API) Sale Market Share by Application (2016-2021)

2.5.2 Global Antibiotics Active Pharmaceutical Ingredient (API) Revenue and Market Share by Application (2016-2021)

2.5.3 Global Antibiotics Active Pharmaceutical Ingredient (API) Sale Price by Application (2016-2021)

3 Global Antibiotics Active Pharmaceutical Ingredient (API) by Company

3.1 Global Antibiotics Active Pharmaceutical Ingredient (API) Sales Market Share by Company

3.1.1 Global Antibiotics Active Pharmaceutical Ingredient (API) Sales by Company (2019-2021)

3.1.2 Global Antibiotics Active Pharmaceutical Ingredient (API) Sales Market Share by Company (2019-2021)

3.2 Global Antibiotics Active Pharmaceutical Ingredient (API) Revenue Market Share by Company

3.2.1 Global Antibiotics Active Pharmaceutical Ingredient (API) Revenue by Company (2019-2021)

3.2.2 Global Antibiotics Active Pharmaceutical Ingredient (API) Revenue Market Share by Company (2019-2021)

3.3 Global Antibiotics Active Pharmaceutical Ingredient (API) Sale Price by Company

3.4 Global Manufacturers Antibiotics Active Pharmaceutical Ingredient (API) Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Antibiotics Active Pharmaceutical Ingredient (API) Product Location Distribution

3.4.2 Players Antibiotics Active Pharmaceutical Ingredient (API) Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 Antibiotics Active Pharmaceutical Ingredient (API) by Region

4.1 Global Antibiotics Active Pharmaceutical Ingredient (API) by Region

4.1.1 Global Antibiotics Active Pharmaceutical Ingredient (API) Sales by Region

4.1.2 Global Antibiotics Active Pharmaceutical Ingredient (API) Revenue by Region

4.2 Americas Antibiotics Active Pharmaceutical Ingredient (API) Sales Growth

4.3 APAC Antibiotics Active Pharmaceutical Ingredient (API) Sales Growth

4.4 Europe Antibiotics Active Pharmaceutical Ingredient (API) Sales Growth

4.5 Middle East & Africa Antibiotics Active Pharmaceutical Ingredient (API) Sales Growth

5 Americas

5.1 Americas Antibiotics Active Pharmaceutical Ingredient (API) Sales by Country

5.1.1 Americas Antibiotics Active Pharmaceutical Ingredient (API) Sales by Country (2016-2021)

5.1.2 Americas Antibiotics Active Pharmaceutical Ingredient (API) Revenue by Country (2016-2021)

5.2 Americas Antibiotics Active Pharmaceutical Ingredient (API) Sales by Type

5.3 Americas Antibiotics Active Pharmaceutical Ingredient (API) Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Antibiotics Active Pharmaceutical Ingredient (API) Sales by Region

6.1.1 APAC Antibiotics Active Pharmaceutical Ingredient (API) Sales by Region (2016-2021)

6.1.2 APAC Antibiotics Active Pharmaceutical Ingredient (API) Revenue by Region (2016-2021)

6.2 APAC Antibiotics Active Pharmaceutical Ingredient (API) Sales by Type

6.3 APAC Antibiotics Active Pharmaceutical Ingredient (API) Sales by Application

6.4 China

6.5 Japan

6.6 Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

7 Europe

7.1 Europe Antibiotics Active Pharmaceutical Ingredient (API) by Country

7.1.1 Europe Antibiotics Active Pharmaceutical Ingredient (API) Sales by Country (2016-2021)

7.1.2 Europe Antibiotics Active Pharmaceutical Ingredient (API) Revenue by Country (2016-2021)

7.2 Europe Antibiotics Active Pharmaceutical Ingredient (API) Sales by Type

7.3 Europe Antibiotics Active Pharmaceutical Ingredient (API) Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Antibiotics Active Pharmaceutical Ingredient (API) by Country

8.1.1 Middle East & Africa Antibiotics Active Pharmaceutical Ingredient (API) Sales by Country (2016-2021)

8.1.2 Middle East & Africa Antibiotics Active Pharmaceutical Ingredient (API) Revenue by Country (2016-2021)

8.2 Middle East & Africa Antibiotics Active Pharmaceutical Ingredient (API) Sales by Type

8.3 Middle East & Africa Antibiotics Active Pharmaceutical Ingredient (API) Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Country

9 Market Drivers, Challenges and Trends

9.1 Market Drivers and Impact

9.1.1 Growing Demand from Key Regions

9.1.2 Growing Demand from Key Applications and Potential Industries

9.2 Market Challenges and Impact

9.3 Market Trends

10 Marketing, Distributors and Customer

10.1 Sales Channel

10.1.1 Direct Channels

10.1.2 Indirect Channels

10.2 Antibiotics Active Pharmaceutical Ingredient (API) Distributors

10.3 Antibiotics Active Pharmaceutical Ingredient (API) Customer

11 Global Antibiotics Active Pharmaceutical Ingredient (API) Market Forecast

11.1 Global Antibiotics Active Pharmaceutical Ingredient (API) Forecast by Region

11.1.1 Global Antibiotics Active Pharmaceutical Ingredient (API) Forecast by Regions (2021-2026)

11.2.2 Global Antibiotics Active Pharmaceutical Ingredient (API) Revenue Forecast by Regions (2021-2026)

11.2 Americas Forecast by Country

11.3 APAC Forecast by Region

11.4 Europe Forecast by Country

11.5 Middle East & Africa Forecast by Country

11.6 Global Antibiotics Active Pharmaceutical Ingredient (API) Forecast by Type

11.7 Global Antibiotics Active Pharmaceutical Ingredient (API) Forecast by Application

12 Key Players Analysis

12.1 Sandoz International

12.1.1 Sandoz International Company Information

12.1.2 Sandoz International Antibiotics Active Pharmaceutical Ingredient (API) Product Offered

12.1.3 Sandoz International Antibiotics Active Pharmaceutical Ingredient (API) Sales, Revenue, Price and Gross Margin (2019-2021)

12.1.4 Sandoz International Main Business Overview

12.1.5 Sandoz International Latest Developments

12.2 Centrient Pharmaceuticals

12.2.1 Centrient Pharmaceuticals Company Information

12.2.2 Centrient Pharmaceuticals Antibiotics Active Pharmaceutical Ingredient (API) Product Offered

12.2.3 Centrient Pharmaceuticals Antibiotics Active Pharmaceutical Ingredient (API) Sales, Revenue, Price and Gross Margin (2019-2021)

12.2.4 Centrient Pharmaceuticals Main Business Overview

12.2.5 Centrient Pharmaceuticals Latest Developments

12.3 CordenPharma International

12.3.1 CordenPharma International Company Information

12.3.2 CordenPharma International Antibiotics Active Pharmaceutical Ingredient (API) Product Offered

12.3.3 CordenPharma International Antibiotics Active Pharmaceutical Ingredient (API) Sales, Revenue, Price and Gross Margin (2019-2021)

12.3.4 CordenPharma International Main Business Overview

12.3.5 CordenPharma International Latest Developments

12.4 ACS DOBFAR

12.4.1 ACS DOBFAR Company Information

12.4.2 ACS DOBFAR Antibiotics Active Pharmaceutical Ingredient (API) Product Offered

12.4.3 ACS DOBFAR Antibiotics Active Pharmaceutical Ingredient (API) Sales, Revenue, Price and Gross Margin (2019-2021)

12.4.4 ACS DOBFAR Main Business Overview

12.4.5 ACS DOBFAR Latest Developments

12.5 Nanjing Dorra Pharmaceutical Technology

12.5.1 Nanjing Dorra Pharmaceutical Technology Company Information

12.5.2 Nanjing Dorra Pharmaceutical Technology Antibiotics Active Pharmaceutical Ingredient (API) Product Offered

12.5.3 Nanjing Dorra Pharmaceutical Technology Antibiotics Active Pharmaceutical Ingredient (API) Sales, Revenue, Price and Gross Margin (2019-2021)

12.5.4 Nanjing Dorra Pharmaceutical Technology Main Business Overview

12.5.5 Nanjing Dorra Pharmaceutical Technology Latest Developments

12.6 DAEWOONG PHARMACEUTICAL

12.6.1 DAEWOONG PHARMACEUTICAL Company Information

12.6.2 DAEWOONG PHARMACEUTICAL Antibiotics Active Pharmaceutical Ingredient (API) Product Offered

12.6.3 DAEWOONG PHARMACEUTICAL Antibiotics Active Pharmaceutical Ingredient (API) Sales, Revenue, Price and Gross Margin (2019-2021)

12.6.4 DAEWOONG PHARMACEUTICAL Main Business Overview

12.6.5 DAEWOONG PHARMACEUTICAL Latest Developments

12.7 Parabolic Drugs

12.7.1 Parabolic Drugs Company Information

12.7.2 Parabolic Drugs Antibiotics Active Pharmaceutical Ingredient (API) Product Offered

12.7.3 Parabolic Drugs Antibiotics Active Pharmaceutical Ingredient (API) Sales, Revenue, Price and Gross Margin (2019-2021)

12.7.4 Parabolic Drugs Main Business Overview

12.7.5 Parabolic Drugs Latest Developments

12.8 Penam Laboratories

12.8.1 Penam Laboratories Company Information

12.8.2 Penam Laboratories Antibiotics Active Pharmaceutical Ingredient (API) Product Offered

12.8.3 Penam Laboratories Antibiotics Active Pharmaceutical Ingredient (API) Sales, Revenue, Price and Gross Margin (2019-2021)

12.8.4 Penam Laboratories Main Business Overview

12.8.5 Penam Laboratories Latest Developments

12.9 ASIATIC DRUGS & PHARMACEUTICALS

12.9.1 ASIATIC DRUGS & PHARMACEUTICALS Company Information

12.9.2 ASIATIC DRUGS & PHARMACEUTICALS Antibiotics Active Pharmaceutical Ingredient (API) Product Offered

12.9.3 ASIATIC DRUGS & PHARMACEUTICALS Antibiotics Active Pharmaceutical Ingredient (API) Sales, Revenue, Price and Gross Margin (2019-2021)

12.9.4 ASIATIC DRUGS & PHARMACEUTICALS Main Business Overview

12.9.5 ASIATIC DRUGS & PHARMACEUTICALS Latest Developments

12.10 Fresenius Kabi

12.10.1 Fresenius Kabi Company Information

12.10.2 Fresenius Kabi Antibiotics Active Pharmaceutical Ingredient (API) Product Offered

12.10.3 Fresenius Kabi Antibiotics Active Pharmaceutical Ingredient (API) Sales, Revenue, Price and Gross Margin (2019-2021)

12.10.4 Fresenius Kabi Main Business Overview

12.10.5 Fresenius Kabi Latest Developments

12.11 The United Laboratories International Holdings

12.11.1 The United Laboratories International Holdings Company Information

12.11.2 The United Laboratories International Holdings Antibiotics Active Pharmaceutical Ingredient (API) Product Offered

12.11.3 The United Laboratories International Holdings Antibiotics Active Pharmaceutical Ingredient (API) Sales, Revenue, Price and Gross Margin (2019-2021)

12.11.4 The United Laboratories International Holdings Main Business Overview

12.11.5 The United Laboratories International Holdings Latest Developments

12.12 Aurobindo Pharma

12.12.1 Aurobindo Pharma Company Information

12.12.2 Aurobindo Pharma Antibiotics Active Pharmaceutical Ingredient (API) Product Offered

12.12.3 Aurobindo Pharma Antibiotics Active Pharmaceutical Ingredient (API) Sales, Revenue, Price and Gross Margin (2019-2021)

12.12.4 Aurobindo Pharma Main Business Overview

12.12.5 Aurobindo Pharma Latest Developments

12.13 Unimark Remedies

12.13.1 Unimark Remedies Company Information

12.13.2 Unimark Remedies Antibiotics Active Pharmaceutical Ingredient (API) Product Offered

12.13.3 Unimark Remedies Antibiotics Active Pharmaceutical Ingredient (API) Sales, Revenue, Price and Gross Margin (2019-2021)

12.13.4 Unimark Remedies Main Business Overview

12.13.5 Unimark Remedies Latest Developments

12.14 Savior Lifetec

12.14.1 Savior Lifetec Company Information

12.14.2 Savior Lifetec Antibiotics Active Pharmaceutical Ingredient (API) Product Offered

12.14.3 Savior Lifetec Antibiotics Active Pharmaceutical Ingredient (API) Sales, Revenue, Price and Gross Margin (2019-2021)

12.14.4 Savior Lifetec Main Business Overview

12.14.5 Savior Lifetec Latest Developments

12.15 Shenzhen Haibin Pharmaceutical

12.15.1 Shenzhen Haibin Pharmaceutical Company Information

12.15.2 Shenzhen Haibin Pharmaceutical Antibiotics Active Pharmaceutical Ingredient (API) Product Offered

12.15.3 Shenzhen Haibin Pharmaceutical Antibiotics Active Pharmaceutical Ingredient (API) Sales, Revenue, Price and Gross Margin (2019-2021)

12.15.4 Shenzhen Haibin Pharmaceutical Main Business Overview

12.15.5 Shenzhen Haibin Pharmaceutical Latest Developments

12.16 Sterile India

12.16.1 Sterile India Company Information

12.16.2 Sterile India Antibiotics Active Pharmaceutical Ingredient (API) Product Offered

12.16.3 Sterile India Antibiotics Active Pharmaceutical Ingredient (API) Sales, Revenue, Price and Gross Margin (2019-2021)

12.16.4 Sterile India Main Business Overview

12.16.5 Sterile India Latest Developments

12.17 Zhejiang Jiuzhou Pharmaceutical

12.17.1 Zhejiang Jiuzhou Pharmaceutical Company Information

12.17.2 Zhejiang Jiuzhou Pharmaceutical Antibiotics Active Pharmaceutical Ingredient (API) Product Offered

12.17.3 Zhejiang Jiuzhou Pharmaceutical Antibiotics Active Pharmaceutical Ingredient (API) Sales, Revenue, Price and Gross Margin (2019-2021)

12.17.4 Zhejiang Jiuzhou Pharmaceutical Main Business Overview

12.17.5 Zhejiang Jiuzhou Pharmaceutical Latest Developments

12.18 Kyongbo Pharm

12.18.1 Kyongbo Pharm Company Information

12.18.2 Kyongbo Pharm Antibiotics Active Pharmaceutical Ingredient (API) Product Offered

12.18.3 Kyongbo Pharm Antibiotics Active Pharmaceutical Ingredient (API) Sales, Revenue, Price and Gross Margin (2019-2021)

12.18.4 Kyongbo Pharm Main Business Overview

12.18.5 Kyongbo Pharm Latest Developments

13 Research Findings and Conclusion

List of Tables

Table 1. Antibiotics Active Pharmaceutical Ingredient (API) Consumption CAGR by Region (2020-2026) & ($ Millions)

Table 2. Major Players of Penicillin Antibiotics

Table 3. Major Players of Cephalosporins

Table 4. Major Players of Carbapenem Antibiotics

Table 5. Global Antibiotics Active Pharmaceutical Ingredient (API) Sales by Type (2016-2021) & (Tons)

Table 6. Global Antibiotics Active Pharmaceutical Ingredient (API) Sales Market Share by Type (2016-2021)

Table 7. Global Antibiotics Active Pharmaceutical Ingredient (API) Revenue by Type (2016-2021) & ($ million)

Table 8. Global Antibiotics Active Pharmaceutical Ingredient (API) Revenue Market Share by Type (2016-2021)

Table 9. Global Antibiotics Active Pharmaceutical Ingredient (API) Sale Price by Type (2016-2021)

Table 10. Global Antibiotics Active Pharmaceutical Ingredient (API) Sales by Application (2016-2021) & (Tons)

Table 11. Global Antibiotics Active Pharmaceutical Ingredient (API) Sales Market Share by Application (2016-2021)

Table 12. Global Antibiotics Active Pharmaceutical Ingredient (API) Value by Application (2016-2021)

Table 13. Global Antibiotics Active Pharmaceutical Ingredient (API) Revenue Market Share by Application (2016-2021)

Table 14. Global Antibiotics Active Pharmaceutical Ingredient (API) Sale Price by Application (2016-2021)

Table 15. Global Antibiotics Active Pharmaceutical Ingredient (API) Sales by Company (2019-2021) & (Tons)

Table 16. Global Antibiotics Active Pharmaceutical Ingredient (API) Sales Market Share by Company (2019-2021)

Table 17. Global Antibiotics Active Pharmaceutical Ingredient (API) Revenue by Company (2019-2021) ($ Millions)

Table 18. Global Antibiotics Active Pharmaceutical Ingredient (API) Revenue Market Share by Company (2019-2021)

Table 19. Global Antibiotics Active Pharmaceutical Ingredient (API) Sale Price by Company (2019-2021)

Table 20. Key Manufacturers Antibiotics Active Pharmaceutical Ingredient (API) Producing Area Distribution and Sales Area

Table 21. Players Antibiotics Active Pharmaceutical Ingredient (API) Products Offered

Table 22. Antibiotics Active Pharmaceutical Ingredient (API) Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)

Table 23. New Products and Potential Entrants

Table 24. Mergers & Acquisitions, Expansion

Table 25. Global Antibiotics Active Pharmaceutical Ingredient (API) Sales by Region (2016-2021) (Tons)

Table 26. Global Antibiotics Active Pharmaceutical Ingredient (API) Sales Market Share by Region (2016-2021)

Table 27. Global Antibiotics Active Pharmaceutical Ingredient (API) Revenue by Region (2016-2021) & ($ Millions)

Table 28. Global Antibiotics Active Pharmaceutical Ingredient (API) Revenue Market Share by Region (2016-2021)

Table 29. Americas Antibiotics Active Pharmaceutical Ingredient (API) Sales by Country (2016-2021) & (Tons)

Table 30. Americas Antibiotics Active Pharmaceutical Ingredient (API) Sales Market Share by Country (2016-2021)

Table 31. Americas Antibiotics Active Pharmaceutical Ingredient (API) Revenue by Country (2016-2021) & ($ Millions)

Table 32. Americas Antibiotics Active Pharmaceutical Ingredient (API) Revenue Market Share by Country (2016-2021)

Table 33. Americas Antibiotics Active Pharmaceutical Ingredient (API) Sales by Type (2016-2021) & (Tons)

Table 34. Americas Antibiotics Active Pharmaceutical Ingredient (API) Sales Market Share by Type (2016-2021)

Table 35. Americas Antibiotics Active Pharmaceutical Ingredient (API) Sales by Application (2016-2021) & (Tons)

Table 36. Americas Antibiotics Active Pharmaceutical Ingredient (API) Sales Market Share by Application (2016-2021)

Table 37. APAC Antibiotics Active Pharmaceutical Ingredient (API) Sales by Region (2016-2021) & (Tons)

Table 38. APAC Antibiotics Active Pharmaceutical Ingredient (API) Sales Market Share by Region (2016-2021)

Table 39. APAC Antibiotics Active Pharmaceutical Ingredient (API) Revenue by Region (2016-2021) & ($ Millions)

Table 40. APAC Antibiotics Active Pharmaceutical Ingredient (API) Revenue Market Share by Region (2016-2021)

Table 41. APAC Antibiotics Active Pharmaceutical Ingredient (API) Sales by Type (2016-2021) & (Tons)

Table 42. APAC Antibiotics Active Pharmaceutical Ingredient (API) Sales Market Share by Type (2016-2021)

Table 43. APAC Antibiotics Active Pharmaceutical Ingredient (API) Sales by Application (2016-2021) & (Tons)

Table 44. APAC Antibiotics Active Pharmaceutical Ingredient (API) Sales Market Share by Application (2016-2021)

Table 45. Europe Antibiotics Active Pharmaceutical Ingredient (API) Sales by Country (2016-2021) & (Tons)

Table 46. Europe Antibiotics Active Pharmaceutical Ingredient (API) Sales Market Share by Country (2016-2021)

Table 47. Europe Antibiotics Active Pharmaceutical Ingredient (API) Revenue by Country (2016-2021) & ($ Millions)

Table 48. Europe Antibiotics Active Pharmaceutical Ingredient (API) Revenue Market Share by Country (2016-2021)

Table 49. Europe Antibiotics Active Pharmaceutical Ingredient (API) Sales by Type (2016-2021) & (Tons)

Table 50. Europe Antibiotics Active Pharmaceutical Ingredient (API) Sales Market Share by Type (2016-2021)

Table 51. Europe Antibiotics Active Pharmaceutical Ingredient (API) Sales by Application (2016-2021) & (Tons)

Table 52. Europe Antibiotics Active Pharmaceutical Ingredient (API) Sales Market Share by Application (2016-2021)

Table 53. Middle East & Africa Antibiotics Active Pharmaceutical Ingredient (API) Sales by Country (2016-2021) & (Tons)

Table 54. Middle East & Africa Antibiotics Active Pharmaceutical Ingredient (API) Sales Market Share by Country (2016-2021)

Table 55. Middle East & Africa Antibiotics Active Pharmaceutical Ingredient (API) Revenue by Country (2016-2021) & ($ Millions)

Table 56. Middle East & Africa Antibiotics Active Pharmaceutical Ingredient (API) Revenue Market Share by Country (2016-2021)

Table 57. Middle East & Africa Antibiotics Active Pharmaceutical Ingredient (API) Sales by Type (2016-2021) & (Tons)

Table 58. Middle East & Africa Antibiotics Active Pharmaceutical Ingredient (API) Sales Market Share by Type (2016-2021)

Table 59. Middle East & Africa Antibiotics Active Pharmaceutical Ingredient (API) Sales by Application (2016-2021) & (Tons)

Table 60. Middle East & Africa Antibiotics Active Pharmaceutical Ingredient (API) Sales Market Share by Application (2016-2021)

Table 61. Key and Potential Regions of Antibiotics Active Pharmaceutical Ingredient (API)

Table 62. Key Application and Potential Industries of Antibiotics Active Pharmaceutical Ingredient (API)

Table 63. Key Challenges of Antibiotics Active Pharmaceutical Ingredient (API)

Table 64. Key Trends of Antibiotics Active Pharmaceutical Ingredient (API)

Table 65. Antibiotics Active Pharmaceutical Ingredient (API) Distributors List

Table 66. Antibiotics Active Pharmaceutical Ingredient (API) Customer List

Table 67. Global Antibiotics Active Pharmaceutical Ingredient (API) Sales Forecast by Region (2021-2026) & (Tons)

Table 68. Global Antibiotics Active Pharmaceutical Ingredient (API) Consumption Market Forecast by Region

Table 69. Global Antibiotics Active Pharmaceutical Ingredient (API) Revenue Forecast by Region (2021-2026) & ($ millions)

Table 70. Global Antibiotics Active Pharmaceutical Ingredient (API) Revenue Market Share Forecast by Region (2021-2026)

Table 71. Americas Antibiotics Active Pharmaceutical Ingredient (API) Sales Forecast by Country (2021-2026) & (Tons)

Table 72. Americas Antibiotics Active Pharmaceutical Ingredient (API) Revenue Forecast by Country (2021-2026) & ($ millions)

Table 73. APAC Antibiotics Active Pharmaceutical Ingredient (API) Sales Forecast by Region (2021-2026) & (Tons)

Table 74. APAC Antibiotics Active Pharmaceutical Ingredient (API) Revenue Forecast by Region (2021-2026) & ($ millions)

Table 75. Europe Antibiotics Active Pharmaceutical Ingredient (API) Sales Forecast by Country (2021-2026) & (Tons)

Table 76. Europe Antibiotics Active Pharmaceutical Ingredient (API) Revenue Forecast by Country (2021-2026) & ($ millions)

Table 77. Middle East & Africa Antibiotics Active Pharmaceutical Ingredient (API) Sales Forecast by Country (2021-2026) & (Tons)

Table 78. Middle East & Africa Antibiotics Active Pharmaceutical Ingredient (API) Revenue Forecast by Country (2021-2026) & ($ millions)

Table 79. Global Antibiotics Active Pharmaceutical Ingredient (API) Sales Forecast by Type (2021-2026) & (Tons)

Table 80. Global Antibiotics Active Pharmaceutical Ingredient (API) Sales Market Share Forecast by Type (2021-2026)

Table 81. Global Antibiotics Active Pharmaceutical Ingredient (API) Revenue Forecast by Type (2021-2026) & ($ Millions)

Table 82. Global Antibiotics Active Pharmaceutical Ingredient (API) Revenue Market Share Forecast by Type (2021-2026)

Table 83. Global Antibiotics Active Pharmaceutical Ingredient (API) Sales Forecast by Application (2021-2026) & (Tons)

Table 84. Global Antibiotics Active Pharmaceutical Ingredient (API) Sales Market Share Forecast by Application (2021-2026)

Table 85. Global Antibiotics Active Pharmaceutical Ingredient (API) Revenue Forecast by Application (2021-2026) & ($ Millions)

Table 86. Global Antibiotics Active Pharmaceutical Ingredient (API) Revenue Market Share Forecast by Application (2021-2026)

Table 87. Sandoz International Basic Information, Antibiotics Active Pharmaceutical Ingredient (API) Manufacturing Base, Sales Area and Its Competitors

Table 88. Sandoz International Antibiotics Active Pharmaceutical Ingredient (API) Product Offered

Table 89. Sandoz International Antibiotics Active Pharmaceutical Ingredient (API) Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2019-2021E)

Table 90. Sandoz International Main Business

Table 91. Sandoz International Latest Developments

Table 92. Centrient Pharmaceuticals Basic Information, Antibiotics Active Pharmaceutical Ingredient (API) Manufacturing Base, Sales Area and Its Competitors

Table 93. Centrient Pharmaceuticals Antibiotics Active Pharmaceutical Ingredient (API) Product Offered

Table 94. Centrient Pharmaceuticals Antibiotics Active Pharmaceutical Ingredient (API) Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2019-2021E)

Table 95. Centrient Pharmaceuticals Main Business

Table 96. Centrient Pharmaceuticals Latest Developments

Table 97. CordenPharma International Basic Information, Antibiotics Active Pharmaceutical Ingredient (API) Manufacturing Base, Sales Area and Its Competitors

Table 98. CordenPharma International Antibiotics Active Pharmaceutical Ingredient (API) Product Offered

Table 99. CordenPharma International Antibiotics Active Pharmaceutical Ingredient (API) Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2019-2021E)

Table 100. CordenPharma International Main Business

Table 101. CordenPharma International Latest Developments

Table 102. ACS DOBFAR Basic Information, Antibiotics Active Pharmaceutical Ingredient (API) Manufacturing Base, Sales Area and Its Competitors

Table 103. ACS DOBFAR Antibiotics Active Pharmaceutical Ingredient (API) Product Offered

Table 104. ACS DOBFAR Antibiotics Active Pharmaceutical Ingredient (API) Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2019-2021E)

Table 105. ACS DOBFAR Main Business

Table 106. ACS DOBFAR Latest Developments

Table 107. Nanjing Dorra Pharmaceutical Technology Basic Information, Antibiotics Active Pharmaceutical Ingredient (API) Manufacturing Base, Sales Area and Its Competitors

Table 108. Nanjing Dorra Pharmaceutical Technology Antibiotics Active Pharmaceutical Ingredient (API) Product Offered

Table 109. Nanjing Dorra Pharmaceutical Technology Antibiotics Active Pharmaceutical Ingredient (API) Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2019-2021E)

Table 110. Nanjing Dorra Pharmaceutical Technology Main Business

Table 111. Nanjing Dorra Pharmaceutical Technology Latest Developments

Table 112. DAEWOONG PHARMACEUTICAL Basic Information, Antibiotics Active Pharmaceutical Ingredient (API) Manufacturing Base, Sales Area and Its Competitors

Table 113. DAEWOONG PHARMACEUTICAL Antibiotics Active Pharmaceutical Ingredient (API) Product Offered

Table 114. DAEWOONG PHARMACEUTICAL Antibiotics Active Pharmaceutical Ingredient (API) Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2019-2021E)

Table 115. DAEWOONG PHARMACEUTICAL Main Business

Table 116. DAEWOONG PHARMACEUTICAL Latest Developments

Table 117. Parabolic Drugs Basic Information, Antibiotics Active Pharmaceutical Ingredient (API) Manufacturing Base, Sales Area and Its Competitors

Table 118. Parabolic Drugs Antibiotics Active Pharmaceutical Ingredient (API) Product Offered

Table 119. Parabolic Drugs Antibiotics Active Pharmaceutical Ingredient (API) Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2019-2021E)

Table 120. Parabolic Drugs Main Business

Table 121. Parabolic Drugs Latest Developments

Table 122. Penam Laboratories Basic Information, Antibiotics Active Pharmaceutical Ingredient (API) Manufacturing Base, Sales Area and Its Competitors

Table 123. Penam Laboratories Antibiotics Active Pharmaceutical Ingredient (API) Product Offered

Table 124. Penam Laboratories Antibiotics Active Pharmaceutical Ingredient (API) Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2019-2021E)

Table 125. Penam Laboratories Main Business

Table 126. Penam Laboratories Latest Developments

Table 127. ASIATIC DRUGS & PHARMACEUTICALS Basic Information, Antibiotics Active Pharmaceutical Ingredient (API) Manufacturing Base, Sales Area and Its Competitors

Table 128. ASIATIC DRUGS & PHARMACEUTICALS Antibiotics Active Pharmaceutical Ingredient (API) Product Offered

Table 129. ASIATIC DRUGS & PHARMACEUTICALS Antibiotics Active Pharmaceutical Ingredient (API) Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2019-2021E)

Table 130. ASIATIC DRUGS & PHARMACEUTICALS Main Business

Table 131. ASIATIC DRUGS & PHARMACEUTICALS Latest Developments

Table 132. Fresenius Kabi Basic Information, Antibiotics Active Pharmaceutical Ingredient (API) Manufacturing Base, Sales Area and Its Competitors

Table 133. Fresenius Kabi Antibiotics Active Pharmaceutical Ingredient (API) Product Offered

Table 134. Fresenius Kabi Antibiotics Active Pharmaceutical Ingredient (API) Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2019-2021E)

Table 135. Fresenius Kabi Main Business

Table 136. Fresenius Kabi Latest Developments

Table 137. The United Laboratories International Holdings Basic Information, Antibiotics Active Pharmaceutical Ingredient (API) Manufacturing Base, Sales Area and Its Competitors

Table 138. The United Laboratories International Holdings Antibiotics Active Pharmaceutical Ingredient (API) Product Offered

Table 139. The United Laboratories International Holdings Antibiotics Active Pharmaceutical Ingredient (API) Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2019-2021E)

Table 140. The United Laboratories International Holdings Main Business

Table 141. The United Laboratories International Holdings Latest Developments

Table 142. Aurobindo Pharma Basic Information, Antibiotics Active Pharmaceutical Ingredient (API) Manufacturing Base, Sales Area and Its Competitors

Table 143. Aurobindo Pharma Antibiotics Active Pharmaceutical Ingredient (API) Product Offered

Table 144. Aurobindo Pharma Antibiotics Active Pharmaceutical Ingredient (API) Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2019-2021E)

Table 145. Aurobindo Pharma Main Business

Table 146. Aurobindo Pharma Latest Developments

Table 147. Unimark Remedies Basic Information, Antibiotics Active Pharmaceutical Ingredient (API) Manufacturing Base, Sales Area and Its Competitors

Table 148. Unimark Remedies Antibiotics Active Pharmaceutical Ingredient (API) Product Offered

Table 149. Unimark Remedies Antibiotics Active Pharmaceutical Ingredient (API) Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2019-2021E)

Table 150. Unimark Remedies Main Business

Table 151. Unimark Remedies Latest Developments

Table 152. Savior Lifetec Basic Information, Antibiotics Active Pharmaceutical Ingredient (API) Manufacturing Base, Sales Area and Its Competitors

Table 153. Savior Lifetec Antibiotics Active Pharmaceutical Ingredient (API) Product Offered

Table 154. Savior Lifetec Antibiotics Active Pharmaceutical Ingredient (API) Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2019-2021E)

Table 155. Savior Lifetec Main Business

Table 156. Savior Lifetec Latest Developments

Table 157. Shenzhen Haibin Pharmaceutical Basic Information, Antibiotics Active Pharmaceutical Ingredient (API) Manufacturing Base, Sales Area and Its Competitors

Table 158. Shenzhen Haibin Pharmaceutical Antibiotics Active Pharmaceutical Ingredient (API) Product Offered

Table 159. Shenzhen Haibin Pharmaceutical Antibiotics Active Pharmaceutical Ingredient (API) Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2019-2021E)

Table 160. Shenzhen Haibin Pharmaceutical Main Business

Table 161. Shenzhen Haibin Pharmaceutical Latest Developments

Table 162. Sterile India Basic Information, Antibiotics Active Pharmaceutical Ingredient (API) Manufacturing Base, Sales Area and Its Competitors

Table 163. Sterile India Antibiotics Active Pharmaceutical Ingredient (API) Product Offered

Table 164. Sterile India Antibiotics Active Pharmaceutical Ingredient (API) Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2019-2021E)

Table 165. Sterile India Main Business

Table 166. Sterile India Latest Developments

Table 167. Zhejiang Jiuzhou Pharmaceutical Basic Information, Antibiotics Active Pharmaceutical Ingredient (API) Manufacturing Base, Sales Area and Its Competitors

Table 168. Zhejiang Jiuzhou Pharmaceutical Antibiotics Active Pharmaceutical Ingredient (API) Product Offered

Table 169. Zhejiang Jiuzhou Pharmaceutical Antibiotics Active Pharmaceutical Ingredient (API) Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2019-2021E)

Table 170. Zhejiang Jiuzhou Pharmaceutical Main Business

Table 171. Zhejiang Jiuzhou Pharmaceutical Latest Developments

Table 172. Kyongbo Pharm Basic Information, Antibiotics Active Pharmaceutical Ingredient (API) Manufacturing Base, Sales Area and Its Competitors

Table 173. Kyongbo Pharm Antibiotics Active Pharmaceutical Ingredient (API) Product Offered

Table 174. Kyongbo Pharm Antibiotics Active Pharmaceutical Ingredient (API) Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2019-2021E)

Table 175. Kyongbo Pharm Main Business

Table 176. Kyongbo Pharm Latest Developments

List of Figures

Figure 1. Picture of Antibiotics Active Pharmaceutical Ingredient (API)

Figure 2. Antibiotics Active Pharmaceutical Ingredient (API) Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Antibiotics Active Pharmaceutical Ingredient (API) Sales Growth Rate 2016-2026 (Tons)

Figure 7. Global Antibiotics Active Pharmaceutical Ingredient (API) Revenue Growth Rate 2016-2026 ($ Millions)

Figure 8. Antibiotics Active Pharmaceutical Ingredient (API) Sales by Region (2021 & 2026) & ($ millions)

Figure 9. Product Picture of Penicillin Antibiotics

Figure 10. Product Picture of Cephalosporins

Figure 11. Product Picture of Carbapenem Antibiotics

Figure 12. Global Antibiotics Active Pharmaceutical Ingredient (API) Sales Market Share by Type in 2020

Figure 13. Global Antibiotics Active Pharmaceutical Ingredient (API) Revenue Market Share by Type (2016-2021)

Figure 14. Antibiotics Active Pharmaceutical Ingredient (API) Consumed in Pharmaceutical Companies

Figure 15. Global Antibiotics Active Pharmaceutical Ingredient (API) Market: Pharmaceutical Companies (2016-2021) & (Tons)

Figure 16. Antibiotics Active Pharmaceutical Ingredient (API) Consumed in Contract Manufacturing Organizations (CMOs)

Figure 17. Global Antibiotics Active Pharmaceutical Ingredient (API) Market: Contract Manufacturing Organizations (CMOs) (2016-2021) & (Tons)

Figure 18. Antibiotics Active Pharmaceutical Ingredient (API) Consumed in Contract Development & Manufacturing Organizations (CDMOs)

Figure 19. Global Antibiotics Active Pharmaceutical Ingredient (API) Market: Contract Development & Manufacturing Organizations (CDMOs) (2016-2021) & (Tons)

Figure 20. Global Antibiotics Active Pharmaceutical Ingredient (API) Sales Market Share by Application (2016-2021)

Figure 21. Global Antibiotics Active Pharmaceutical Ingredient (API) Revenue Market Share by Application in 2020

Figure 22. Antibiotics Active Pharmaceutical Ingredient (API) Revenue Market by Company in 2020 ($ Million)

Figure 23. Global Antibiotics Active Pharmaceutical Ingredient (API) Revenue Market Share by Company in 2020

Figure 24. Global Antibiotics Active Pharmaceutical Ingredient (API) Sales Market Share by Regions (2016-2021)

Figure 25. Global Antibiotics Active Pharmaceutical Ingredient (API) Revenue Market Share by Region in 2020

Figure 26. Americas Antibiotics Active Pharmaceutical Ingredient (API) Sales 2016-2021 (Tons)

Figure 27. Americas Antibiotics Active Pharmaceutical Ingredient (API) Revenue 2016-2021 ($ Millions)

Figure 28. APAC Antibiotics Active Pharmaceutical Ingredient (API) Sales 2016-2021 (Tons)

Figure 29. APAC Antibiotics Active Pharmaceutical Ingredient (API) Revenue 2016-2021 ($ Millions)

Figure 30. Europe Antibiotics Active Pharmaceutical Ingredient (API) Sales 2016-2021 (Tons)

Figure 31. Europe Antibiotics Active Pharmaceutical Ingredient (API) Revenue 2016-2021 ($ Millions)

Figure 32. Middle East & Africa Antibiotics Active Pharmaceutical Ingredient (API) Sales 2016-2021 (Tons)

Figure 33. Middle East & Africa Antibiotics Active Pharmaceutical Ingredient (API) Revenue 2016-2021 ($ Millions)

Figure 34. Americas Antibiotics Active Pharmaceutical Ingredient (API) Sales Market Share by Country in 2020

Figure 35. Americas Antibiotics Active Pharmaceutical Ingredient (API) Revenue Market Share by Country in 2020

Figure 36. Americas Antibiotics Active Pharmaceutical Ingredient (API) Sales Market Share by Type in 2020

Figure 37. Americas Antibiotics Active Pharmaceutical Ingredient (API) Sales Market Share by Application in 2020

Figure 38. United States Antibiotics Active Pharmaceutical Ingredient (API) Revenue Growth 2016-2021 ($ Millions)

Figure 39. Canada Antibiotics Active Pharmaceutical Ingredient (API) Revenue Growth 2016-2021 ($ Millions)

Figure 40. Mexico Antibiotics Active Pharmaceutical Ingredient (API) Revenue Growth 2016-2021 ($ Millions)

Figure 41. Brazil Antibiotics Active Pharmaceutical Ingredient (API) Revenue Growth 2016-2021 ($ Millions)

Figure 42. APAC Antibiotics Active Pharmaceutical Ingredient (API) Sales Market Share by Region in 2020

Figure 43. APAC Antibiotics Active Pharmaceutical Ingredient (API) Revenue Market Share by Regions in 2020

Figure 44. APAC Antibiotics Active Pharmaceutical Ingredient (API) Sales Market Share by Type in 2020

Figure 45. APAC Antibiotics Active Pharmaceutical Ingredient (API) Sales Market Share by Application in 2020

Figure 46. China Antibiotics Active Pharmaceutical Ingredient (API) Revenue Growth 2016-2021 ($ Millions)

Figure 47. Japan Antibiotics Active Pharmaceutical Ingredient (API) Revenue Growth 2016-2021 ($ Millions)

Figure 48. Korea Antibiotics Active Pharmaceutical Ingredient (API) Revenue Growth 2016-2021 ($ Millions)

Figure 49. Southeast Asia Antibiotics Active Pharmaceutical Ingredient (API) Revenue Growth 2016-2021 ($ Millions)

Figure 50. India Antibiotics Active Pharmaceutical Ingredient (API) Revenue Growth 2016-2021 ($ Millions)

Figure 51. Australia Antibiotics Active Pharmaceutical Ingredient (API) Revenue Growth 2016-2021 ($ Millions)

Figure 52. Europe Antibiotics Active Pharmaceutical Ingredient (API) Sales Market Share by Country in 2020

Figure 53. Europe Antibiotics Active Pharmaceutical Ingredient (API) Revenue Market Share by Country in 2020

Figure 54. Europe Antibiotics Active Pharmaceutical Ingredient (API) Sales Market Share by Type in 2020

Figure 55. Europe Antibiotics Active Pharmaceutical Ingredient (API) Sales Market Share by Application in 2020

Figure 56. Germany Antibiotics Active Pharmaceutical Ingredient (API) Revenue Growth 2016-2021 ($ Millions)

Figure 57. France Antibiotics Active Pharmaceutical Ingredient (API) Revenue Growth 2016-2021 ($ Millions)

Figure 58. UK Antibiotics Active Pharmaceutical Ingredient (API) Revenue Growth 2016-2021 ($ Millions)

Figure 59. Italy Antibiotics Active Pharmaceutical Ingredient (API) Revenue Growth 2016-2021 ($ Millions)

Figure 60. Russia Antibiotics Active Pharmaceutical Ingredient (API) Revenue Growth 2016-2021 ($ Millions)

Figure 61. Middle East & Africa Antibiotics Active Pharmaceutical Ingredient (API) Sales Market Share by Country in 2020

Figure 62. Middle East & Africa Antibiotics Active Pharmaceutical Ingredient (API) Revenue Market Share by Country in 2020

Figure 63. Middle East & Africa Antibiotics Active Pharmaceutical Ingredient (API) Sales Market Share by Type in 2020

Figure 64. Middle East & Africa Antibiotics Active Pharmaceutical Ingredient (API) Sales Market Share by Application in 2020

Figure 65. Egypt Antibiotics Active Pharmaceutical Ingredient (API) Revenue Growth 2016-2021 ($ Millions)

Figure 66. South Africa Antibiotics Active Pharmaceutical Ingredient (API) Revenue Growth 2016-2021 ($ Millions)

Figure 67. Israel Antibiotics Active Pharmaceutical Ingredient (API) Revenue Growth 2016-2021 ($ Millions)

Figure 68. Turkey Antibiotics Active Pharmaceutical Ingredient (API) Revenue Growth 2016-2021 ($ Millions)

Figure 69. GCC Country Antibiotics Active Pharmaceutical Ingredient (API) Revenue Growth 2016-2021 ($ Millions)

Figure 70. Channels of Distribution

Figure 71. Distributors Profiles

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025

The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...

  • Publish Date: June 24, 2019
  • $1050
Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts

The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...

  • Publish Date: February 18, 2019
  • $1290
Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts

The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...

  • Publish Date: December 11, 2018
  • $1390